Sumile, Renalyn D.
HRN: 28-90-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2026
CO-AMOXICLAV 625MG (TAB)
04/23/2026
04/29/2026
PO
625mg
Q8h
UTI After Pregnancy
Checking Initial Appropriateness